The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

NCT ID: NCT06733662

Last Updated: 2024-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-15

Study Completion Date

2025-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial will be conducted to evaluate the effect of education and motivational interviewing on treatment adherence and self-care power in COPD patients.

Hypotheses of the Study; H1: Education and motivational interviewing in COPD patients increase treatment adherence in patients.

H2: Education and motivational interviewing in COPD patients increase self-care power in patients.

There will be two groups in the study: control and intervention groups. Before the intervention, pre-test data will be collected in the control and intervention groups. After the intervention, post-test data will be collected in both groups in line with the data collection forms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In line with the randomization list, patients will be assigned to the intervention and control groups in line with the inclusion criteria. Pre-test data will be collected face-to-face in the intervention group in accordance with the data collection forms. After collecting the pre-test data, the patient will be allowed to rest for about 10 minutes, and then COPD training will be given to the patient in a single session lasting about 45-50 minutes in line with the training booklet and by evaluating the pre-test data. The education booklet will be given to the patient. On the 3rd day, the first session of motivational interview will be held. On the 5th day and 7th day and 15th day, motivational interview sessions will continue with the patients. During the motivational interview, patients will be supported in line with the training booklet. On the 30th day, the patient will be interviewed face-to-face and post-test data will be collected.

Patients in the control group will be interviewed and no intervention will be made after the pre-tests are applied. Patients in the control group will continue their routine controls. In the final test (1st month), an appointment date will be set with the patient and the final test data will be collected face-to-face.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motivational Interviewing COPD

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Self-care Treatment adherence Education

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Education-based motivational interviewing Group

Patients in the intervention group will be given COPD education lasting approximately 45-50 minutes in a single session in line with the education booklet and by evaluating the pre-test data. On the 3rd day, the first session of motivational interview will be held. On the 5th day and 7th day and 15th day, motivational interview sessions will continue with the patients.

Group Type EXPERIMENTAL

Experimental: Education-based motivational interviewing Group

Intervention Type BEHAVIORAL

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Control group

There will be no intervention for individuals in this group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental: Education-based motivational interviewing Group

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of COPD for at least 6 months
* Admitted to the chest clinic
* No communication problems
* Patients who volunteered to participate in the study.

Exclusion Criteria

* In the period of exacerbation
* Uncooperative due to dyspnea
* With a malignant disease
* Patients with a confirmed diagnosis of psychiatric illness
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kahramanmaraş İstiklal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yasemin Sazak

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kahramanmaraş Istiklal Universty

Kahramanmaraş, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yasemin SAZAK

Role: CONTACT

Phone: 541 447 49 44

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yasemin SAZAK

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IstiklalU-YSazak-003

Identifier Type: -

Identifier Source: org_study_id